TY - JOUR
T1 - Vitamin K Dependent Protection of Renal Function in Multi-ethnic Population Studies
AU - Wei, Fang-Fei
AU - Drummen, Nadja E. A.
AU - Schutte, Aletta E.
AU - Thijs, Lutgarde
AU - Jacobs, Lotte
AU - Petit, Thibaut
AU - Yang, Wen-Yi
AU - Smith, Wayne
AU - Zhang, Zhen-Yu
AU - Gu, Yu-Mei
AU - Kuznetsova, Tatiana
AU - Verhamme, Peter
AU - Allegaert, Karel
AU - Schutte, Rudolph
AU - Lerut, Evelyne
AU - Evenepoel, Pieter
AU - Vermeer, Cees
AU - Staessen, Jan A.
PY - 2016/2
Y1 - 2016/2
N2 - Background: Following activation by vitamin K (VK), matrix Gla protein (MGP) inhibits arterial calcification, but its role in preserving renal function remains unknown. Methods: In 1166 white Flemish (mean age, 38.2 years) and 714 South Africans (49.2% black; 40.6 years), we correlated estimated glomerular filtration (eGFR [CKD-EPI formula]) and stage of chronic kidney disease (CKD [KDOQI stages 2-3]) with inactive desphospho-uncarboxylated MGP (dp-ucMGP), using multivariable linear and logistic regression. Results: Among Flemish and white and black Africans, between-group differences in eGFR (90, 100 and 122 mL/min/1.73 m(2)), dp-ucMGP (3.7, 6.5 and 3.2 mu g/L), and CKD prevalence (53.5, 28.7 and 10.5%) were significant, but associations of eGFR with dp-ucMGP did not differ among ethnicities (P >= 0.075). For a doubling of dp-ucMGP, eGFR decreased by 1.5 (P = 0.023), 1.0 (P = 0.56), 2.8 (P = 0.0012) and 2.1 (P <0.0001) mL/min/1.73 m(2) in Flemish, white Africans, black Africans and all participants combined; the odds ratios for moving up one CKD stage were 1.17 (P = 0.033), 1.03 (P = 0.87), 1.29 (P = 0.12) and 1.17 (P = 0.011), respectively. Interpretation: In the general population, eGFR decreases and CKD risk increaseswith higher dp-ucMGP, a marker of VK deficiency. These findings highlight the possibility that VK supplementation might promote renal health.
AB - Background: Following activation by vitamin K (VK), matrix Gla protein (MGP) inhibits arterial calcification, but its role in preserving renal function remains unknown. Methods: In 1166 white Flemish (mean age, 38.2 years) and 714 South Africans (49.2% black; 40.6 years), we correlated estimated glomerular filtration (eGFR [CKD-EPI formula]) and stage of chronic kidney disease (CKD [KDOQI stages 2-3]) with inactive desphospho-uncarboxylated MGP (dp-ucMGP), using multivariable linear and logistic regression. Results: Among Flemish and white and black Africans, between-group differences in eGFR (90, 100 and 122 mL/min/1.73 m(2)), dp-ucMGP (3.7, 6.5 and 3.2 mu g/L), and CKD prevalence (53.5, 28.7 and 10.5%) were significant, but associations of eGFR with dp-ucMGP did not differ among ethnicities (P >= 0.075). For a doubling of dp-ucMGP, eGFR decreased by 1.5 (P = 0.023), 1.0 (P = 0.56), 2.8 (P = 0.0012) and 2.1 (P <0.0001) mL/min/1.73 m(2) in Flemish, white Africans, black Africans and all participants combined; the odds ratios for moving up one CKD stage were 1.17 (P = 0.033), 1.03 (P = 0.87), 1.29 (P = 0.12) and 1.17 (P = 0.011), respectively. Interpretation: In the general population, eGFR decreases and CKD risk increaseswith higher dp-ucMGP, a marker of VK deficiency. These findings highlight the possibility that VK supplementation might promote renal health.
KW - Chronic kidney disease
KW - Glomerular filtration rate
KW - Matrix Gla protein
KW - Population science
KW - Vitamin K
U2 - 10.1016/j.ebiom.2016.01.011
DO - 10.1016/j.ebiom.2016.01.011
M3 - Article
C2 - 26981580
SN - 2352-3964
VL - 4
SP - 162
EP - 169
JO - EBioMedicine
JF - EBioMedicine
ER -